EMA important links on EU process for approval of Covid-19 vaccines
EMA held this virtual meeting to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines in the EU, including EMA’s […]
State aid: EU Commission gives green light to the Pan-European Guarantee Fund to enable up to €200 billion …
…financing for companies affected by the coronavirus outbreak in 21 Member States The European Commission found the creation of a €25 billion Pan-European Guarantee Fund […]
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced additional data on neutralizing antibody and T cell responses from the Phase 1/2 trial […]
U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization […]
Pfizer and BioNTech Vaccine to Prevent COVID-19 IMPORTANT SAFETY INFORMATION
Do not administer Pfizer‑BioNTech COVID-19 Vaccine to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the Pfizer‑BioNTech COVID-19 […]
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19
U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediately Pfizer Inc. (NYSE: PFE) and […]
EU and Member States Vaccine strategies and bestpractices – priority groups
The Commission has been working closely with Member States to define needs, explore strategies and to exchange information and best practices. In addition, modernising public […]
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory […]
Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine
Data from 43,448 participants, half of whom received BNT162b2 and half of whom received placebo, showed that the vaccine candidate was well tolerated and demonstrated […]
Pfizer and BioNTech Achieve Health Canada Authorization for Their Vaccine to Combat COVID-19
Pfizer Canada and BioNTech SE (Nasdaq: BNTX) today announced that Health Canada has granted Authorization under Interim Order for the emergency use of their mRNA […]
NASA Science, New Airlock Heads to Space Station on SpaceX Cargo Spacecraft
SpaceX launched its 21st commercial resupply mission to the International Space Station at 11:17 a.m. EST Dec. 6, 2020, from Launch Pad 39A at NASA’s […]
European Medicines Agency EMA has Launched Third Rolling Review of a COVID-19 Vaccine Candidate for Europe
The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has started the third rolling review process, the evaluation of […]